More Than Half of Melanomas Are Self-Detected

Share this content:
More Than Half of Melanomas Are Self-Detected
More Than Half of Melanomas Are Self-Detected

TUESDAY, Oct. 25, 2016 (HealthDay News) -- More than half of melanomas are self-detected, and more melanomas are self-detected by women than men, according to a study published in the November issue of the Journal of the American Academy of Dermatology.

José Antonio Avilés-Izquierdo, Ph.D., from Hospital General Universitario "Gregorio Marañón" in Madrid, and colleagues examined who first detects melanoma in a study involving 783 patients diagnosed with cutaneous melanoma between 1996 and 2012. The authors assessed correlations between who noticed the melanoma, epidemiology, clinical presentation, histology, and patient outcomes.

The researchers found that 53 percent of melanomas were self-detected. Bleeding, itching/pain, and/or nodule enlargement were the reasons for consulting in 32 percent of these patients. More melanomas were self-detected among women, with better prognosis. Compared with women, men had significantly more melanomas in non-easily visible locations. Eighty percent of melanomas noticed by dermatologists were incidental findings. Self-detected melanomas were thicker and more often ulcerated, developed metastases more frequently, and correlated with more melanoma-related deaths.

"Patients with melanomas that were self-detected by women had better prognoses than those that were self-detected by men, especially for patients >70 years of age," the authors write. "This group might therefore be a logical target for melanoma detection education."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Artificial Intelligence Promising for CA, Retinopathy Diagnoses

Artificial Intelligence Promising for CA, Retinopathy Diagnoses

Two studies evaluate use; one for breast cancer, the other for diabetic retinopathy

USPSTF Recommends Against Hormone Tx Post Menopause

USPSTF Recommends Against Hormone Tx Post Menopause

Benefits do not outweigh harms of using hormone therapy for prevention of chronic conditions

Omalizumab Ups Efficacy of Multifood Oral Immunotherapy

Omalizumab Ups Efficacy of Multifood Oral Immunotherapy

Findings in multifood allergic pediatric patients

is free, fast, and customized just for you!

Already a member?

Sign In Now »